Company news

Amphastar Pharmaceuticals, Inc. news in 2025

Amphastar Pharmaceuticals, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Amphastar Announces FDA Approval for Teriparatide Injection

December 14, 2025

Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference

November 23, 2025

Q2 Financial Results (AMP 2025 Q2 Earnings Release FINAL)

November 20, 2025

Q1 Financial Results (AMP 2025 Q1 Earnings Release FINAL)

November 20, 2025

Q3 Financial Results (AMP 2025 Q3 Earnings Release FINAL)

November 20, 2025

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

November 11, 2025

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025

November 5, 2025

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025

October 26, 2025

Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare Conference

August 27, 2025

Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.

August 11, 2025

Amphastar Announces FDA Approval for Iron Sucrose Injection, USP

August 11, 2025

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025

August 6, 2025

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025

July 28, 2025

Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters

July 13, 2025

Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference

May 8, 2025

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

May 6, 2025

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025

April 29, 2025

Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

April 2, 2025

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

March 27, 2025

Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference

March 4, 2025

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024

February 26, 2025

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025

February 19, 2025

Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 7, 2025

Calls in 2025

Decks in 2025